1,266 results on '"Yang, Jay"'
Search Results
102. A Novel Isoflavone, ME-344, Enhances Venetoclax Antileukemic Activity Against AML Via Suppression of Oxidative Phosphorylation and Purine Biosynthesis
103. A Phase 1/1b Open-Label, Multicenter, Two-Part Study of SETD2 Inhibitor EZM0414 in Patients with Relapsed/Refractory Multiple Myeloma or Diffuse Large B-Cell Lymphoma
104. Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia
105. Interim Analysis of the Randomized Phase 1b/3 Study Evaluating the Safety and Efficacy of Tazemetostat Plus Lenalidomide and Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma
106. Serial time-resolved crystallography of photosystem II using a femtosecond X-ray laser
107. Macromolecular diffractive imaging using imperfect crystals
108. Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis
109. Editorial
110. Metabolism in Retinopathy of Prematurity
111. Homological and combinatorial aspects of virtually Cohen–Macaulay sheaves
112. Poster: IBCL-165: Tazemetostat in Relapsed/Refractory (R/R) Follicular Lymphoma (FL): Propensity Score-Matched Analysis of E7438-G000-101 Trial Outcomes
113. IBCL-165: Tazemetostat in Relapsed/Refractory (R/R) Follicular Lymphoma (FL): Propensity Score-Matched Analysis of E7438-G000-101 Trial Outcomes
114. Gene Therapy for Pain: Will future treatments for one of medicine's most intractable problems include the new genetic technologies?
115. Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax
116. Factors Impacting Response to Olutasidenib in Patients with mIDH1 Acute Myeloid Leukemia
117. A Single Center, 10-Year Experience of CALGB-10403 Regimen in AYA Population with Philadelphia-Chromosome Negative Acute Lymphoblastic Leukemia
118. The Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit the Growth of MLL-r AML
119. HJKC3-007: Outcomes of Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Asciminib and Other Tyrosine Kinase Inhibitors in Routine Clinical Practice
120. Olutasidenib Alone or in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Myelodysplastic Syndromes/Neoplasms (MDS)
121. Functional Roles of N-Linked Glycosylation of Human Matrix Metalloproteinase 9
122. Study of ICT adoption for building project management in the Indian construction industry
123. Selinexor in combination with R-CHOP for frontline treatment of non-Hodgkin lymphoma: results of a phase 1 study
124. Inhibition of Ca 2+ Conductance in Identified Leech Neurons by Benzodiazepines
125. Fanconi anemia signaling and Mus81 cooperate to safeguard development and crosslink repair
126. Pitfalls in the Diagnosis of Myelodysplastic Syndromes
127. Editorial
128. Redox modulation on chloroplast ATP synthase
129. Tazemetostat (TAZ) in relapsed/refractory (R/R) follicular lymphoma (FL): Propensity-score matched analysis of E7438-G000-101 trial outcomes.
130. Editorial
131. PTG-300 Eliminates the Need for Therapeutic Phlebotomy in Both Low and High-Risk Polycythemia Vera Patients
132. β-adrenoceptor blockers protect against staurosporine-induced apoptosis in SH-SY5Y neuroblastoma cells
133. Benchmarking framework to measure extent of ICT adoption for building project management
134. Single nucleotide polymorphism-specific regulation of matrix metalloproteinase-9 by multiple miRNAs targeting the coding exon
135. Cell-blocks and hematolymphoid lesions
136. Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
137. Outcomes of AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Following Treatment with Venetoclax and Hypomethylating Agents
138. Virtual resolutions of monomial ideals on toric varieties
139. Activation of endogenous [GABA.sub.A] channels on airway smooth muscle potentiates isoproterenol-mediated relaxation
140. [GABA.sub.A] receptors are expressed and facilitate relaxation in airway smooth muscle
141. Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells
142. OS-063 - Pemvidutide, a glp-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and body weight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial
143. Role of an alternatively spliced form of αII-spectrin in localization of connexin 43 in cardiomyocytes and regulation by stress-activated protein kinase
144. Editorial
145. [A.sub.1] adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo
146. Inhibition of thrombin activity by a covalent-binding aptamer and reversal by the complementary strand antidote
147. Real‐world outcomes of patients with locally advanced or metastatic epithelioid sarcoma
148. Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
149. Direct Observation of the Mechanism of Antibiotic Resistance by Mix-and-Inject at the European XFEL
150. Hepcidin Mimetic (PTG-300) Reverses Iron Deficiency While Controlling Hematocrit in Polycythemia Vera Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.